Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lewy Body Parkinson Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06745011
What this trial is testing

Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System

Who this might be right for
PolyneuropathyAlpha-SynucleinopathyLewy Body Disease+8 more
University of Aarhus 100
Not applicableStudy completedNCT03552484
What this trial is testing

In-Home Care for Patients With PSP and Related Disorders

Who this might be right for
Progressive Supranuclear PalsyDementia With Lewy BodiesMultiple System Atrophy+2 more
Rush University Medical Center 56
Large-scale testing (Phase 3)Active Not RecruitingNCT04895358
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 342
Testing effectiveness (Phase 2)Looking for participantsNCT06961006
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Who this might be right for
Malignant Melanoma
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Ended earlyNCT04152863
What this trial is testing

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Who this might be right for
Advanced/Metastatic Melanoma
Merck Sharp & Dohme LLC 85
Not applicableStudy completedNCT03170063
What this trial is testing

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 54
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,854
Not applicableStudy completedNCT05432622
What this trial is testing

Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

Who this might be right for
Melanoma
Bristol-Myers Squibb 95
Testing effectiveness (Phase 2)Study completedNCT03322566
What this trial is testing

Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

Who this might be right for
Lung Cancer
Incyte Corporation 233
Large-scale testing (Phase 3)Study completedNCT04221945
What this trial is testing

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

Who this might be right for
Uterine Cervical Neoplasms
Merck Sharp & Dohme LLC 1,060
Not applicableLooking for participantsNCT07790744
What this trial is testing

A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD

Who this might be right for
REM Sleep Behavior DisorderSynucleinopathiesParkinson's Disease (PD)+1 more
Danish Research Centre for Magnetic Resonance 100
Post-approval studies (Phase 4)Looking for participantsNCT05590637
What this trial is testing

Comparing Antipsychotic Medications in LBD Over Time

Who this might be right for
Parkinson's Disease PsychosisDementia With Lewy Bodies
The University of Texas Health Science Center at San Antonio 94
Testing effectiveness (Phase 2)Study completedNCT03284424
What this trial is testing

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

Who this might be right for
Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 159
Testing effectiveness (Phase 2)UnknownNCT05392686
What this trial is testing

PD1 and PARP for Maintenance Therapy in NSLLC

Who this might be right for
Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 52
Large-scale testing (Phase 3)Active Not RecruitingNCT03553836
What this trial is testing

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 976
Testing effectiveness (Phase 2)Looking for participantsNCT06445972
What this trial is testing

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 210
Testing effectiveness (Phase 2)Study completedNCT02735239
What this trial is testing

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Who this might be right for
Esophageal Cancer
Ludwig Institute for Cancer Research 73
Large-scale testing (Phase 3)Ended earlyNCT04949256
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 863
Large-scale testing (Phase 3)WithdrawnNCT03342352
What this trial is testing

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Who this might be right for
Head and Neck Cancer
Incyte Corporation
Early research (Phase 1)Study completedNCT02964013
What this trial is testing

Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)

Who this might be right for
Neoplasms
Merck Sharp & Dohme LLC 474
Next Page